4//SEC Filing
Arbuckle Stuart A 4
Accession 0000875320-24-000152
CIK 0000875320other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 4:24 PM ET
Size
5.4 KB
Accession
0000875320-24-000152
Insider Transaction Report
Form 4
Arbuckle Stuart A
EVP\Chief Commercial Officer
Transactions
- Sale
Common Stock
2024-05-15$430.93/sh−69$29,734→ 49,691 total
Holdings
- 140(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1, which was entered into on 02/28/2023.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001557290
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 4:24 PM ET
- Size
- 5.4 KB